Glenmark Pharma gets UK regulatory nod for GRC 4039

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Glenmark Pharma gets UK regulatory nod for GRC 4039

Postby Jean » Thu Feb 21, 2008 4:29 am

Glenmark Pharmaceuticals Ltd on February 21 announced that its candidate for Rheumatoid Arthritis, Inflammation and Multiple Sclerosis - GRC 4039, has entered Phase I trials.

This is with approval from the Medicines and Healthcare Products Regulatory Agency [MHRA] in the U.K. The company intends to develop GRC 4039 for Rheumatoid Arthritis.

Glenmark expects to complete Phase I trials for GRC 4039 by October 2008 and initiate Phase II by January 2009.

Source: The Hindu Business Line © 2008, The Hindu Business Line (21/02/08)
User avatar
Jean
Family Member
 
Posts: 47
Joined: Mon May 21, 2007 3:00 pm
Location: France

Advertisement

Postby dignan » Thu Feb 21, 2008 9:43 am

Good enough for me. I'll add to phase 1 of the pipeline list.
User avatar
dignan
Family Elder
 
Posts: 1608
Joined: Wed Aug 11, 2004 3:00 pm


Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users